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We have evaluated how levels of predictors of the cardio-
vascular risk such as: glucose, insulin, total cholesterol,
high-density cholesterol, low-density cholesterol and trigly-
cerides as well as adiponectin, fibrinogen, D-Dimers and
CRP changed 24-28 weeks after treatment of hyperthyroid-
ism in women with low and high titer of antibodies, and if
their levels were different in these groups before and after
treatment of hyperthyroidism. We compared also fT4 level
before and after treatment in study groups.
We investigated 35 postmenopausal women (non-
smoking, aged 51-69 years) with subclinical and overt
hyperthyroidism. We divided them into two groups
according to titer of thyroid peroxidase antibodies: with
low titer of antibodies (27 women) and high titer of anti-
bodies (8 women).
Statistical analysis revealed no difference in lipids pro-
file, coagulation-fibrinolytic system, glucose, insulin, CRP
and adiponectin level (before and after treatment)
between groups with low and high titer of antibodies. No
difference in fT4 level before and after treatment was
found. In women with low titer of antibodies significant
decrease was observed only in fT4 level (20.38 vs. 13.23
ng/ml). Levels of other factors did not differ before and
after treatment. Triglycerides level decreased (133.00 vs.
89.13 mg/dl) and CRP level increased (2.95 vs. 4.48 mg/l)
significantly after treatment in women with high titer of
antibodies.
Data suggest that it is more difficult to become
euthyroid for women with hyperthyroidism and high
titer of antibodies (there is no significant difference
between fT4 level before and after treatment). Changes
in metabolic profile and increase in inflammatory
process are observed in women with hyperthyroidism
and high titer of antibodies.
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